Feedback / Questions
[225Ac]Ac-AKY-807 - Aktis Oncology
[²²⁵Ac]Ac-AKY-1189 - Aktis Oncology
https://www.prnewswire.com/news-releases/aktis-oncology-announces-presentation-of-the-first-clinical-data-supporting-broad-development-of-a-first-in-class-nectin-4-targeting-radiopharmaceutical-aky-1189-at-2024-eortc-nci-aacr-symposium-on-molecular-targets-and-cancer-the-302286329.html
Oct 24, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next